A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.

Dietlind Zohlnhöfer; Jörg Hausleiter; Adnan Kastrati; Julinda Mehilli; Christoph Goos; Helmut Schühlen; Jürgen Pache; Gisela Pogatsa-Murray; Uwe Heemann; Josef Dirschinger

doi:10.1016/j.jacc.2005.07.060

A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.

Identifier:nobleid.org/w1/20260515/2FD94685

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2FD94685.svg?ark=w1%2F20260515%2F2FD94685)](https://nobleid.org/work/w1/20260515/2FD94685)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Gisela Pogatsa-Murray

Uwe Heemann

Josef Dirschinger

Claim authorship of this work

A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.

Identifier:nobleid.org/w1/20260515/2FD94685

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2FD94685.svg?ark=w1%2F20260515%2F2FD94685)](https://nobleid.org/work/w1/20260515/2FD94685)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Gisela Pogatsa-Murray

Uwe Heemann

Josef Dirschinger

Claim authorship of this work